keyboard_arrow_up

2018 Global Pain Management Drugs Market : Growth & Key Vendors Analyzed

ReportsnReports.com adds report Global Pain Management Drugs Market 2014-2018 to its store. R&D activities are increasing due to the strong need for new efficacious and better-tolerated medications. Developing better pain treatments is the main goal of all pain research being conducted by various institutes. Morphine is one such drug that works through the body's natural pain-killing machinery, preventing pain messages from reaching the brain. Patients receiving morphine also face the problem of morphine tolerance. Scientists are working toward the development of a morphine-like drug that will have the pain-deadening qualities of morphine but without the drug's negative side effects, such as sedation and the potential for addiction.

Complete report is available at http://www.reportsnreports.com/reports/278253-global-pain-management-drugs-market-2014-2018.html.

According to the report, one of the main drivers in this market is the increase in global aging population. The rise in aging population has consequently led to an increase in the incidence of diseases such as chronic arthritis, diabetic neuropathy, osteoarthritis, and cancer.

The report, Global Pain Management Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pain Management Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Analyst recognizes the following companies as the key players in Global Pain Management Drugs Market: Abbott Laboratories, Eli Lilly and Co., Endo Health Solutions Inc., Pfizer Inc., Purdue Pharma L.P., Actavis plc, Allergen Inc., Astra Zenca plc, Baxter International Inc., Bayer Healthcare AG, Boehringer Ingelheim GmbH, Boston Scientific Corp., Bristol Myers Squibb Co., Durect Corp., F. Hoffmann La Roche Ltd., Forest Laboratories Inc., GlaxoSmithKline plc, Hospira Inc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pain Therapeutics Inc., Sanofi S.A., St. Jude Medical Inc., UCB S.A., Valeant Pharmaceuticals International Inc., and Zalicus Inc.

Purchase Report Directly @ http://www.reportsnreports.com/purchase.aspx?name=278253.

Key questions answered in this report:

  • What will the market size be in 2018 and what will be the growth rate?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

Table Of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Category

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

18. Other Reports in this Series

List of Exhibits

Inquiry before Buying on this Report Global Pain Management Drugs Market 2014-2018 at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=278253 before making a purchase decision.

About Us:
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com  and we would be happy to help you find the business intelligence that you need. Not limited to the Pharmaceuticals ReportsnReports.com offers research studies on agriculture, consumer goods, environment, advanced materials, public sector, food and beverages, energy and power, medical devices, healthcare, automotive, manufacturing & construction, semiconductor and electronics, IT & telecommunication, pharmaceuticals, retail, water, banking and financial services , advanced materials and much more.